Current treatment options for bone fractures and musculoskeletal injuries aren't sufficient

Patients endure invasive procedures, rely heavily on drugs, and suffer through long recovery timelines

Vira Regen’s mission is to transform recovery by developing novel, impactful bioelectronic medicines; with the vision to enhance the healing process, eliminating the body’s heavy dependency on drugs and invasive treatments.

Vira Regen is a regenerative medicine company pioneering bioelectronic medicines through noninvasive gene therapies and tissue stimulation. 

Bone fractures and musculoskeletal
injuries are unfortunately common:

6.8M bone breaks per year in the US → 
Up to $30,000 US healthcare cost each

  • $2500 for each non-union fractures 

  • 2.7B spent on limited duty days per year

  • 2M annual bone breaks from bone disease (ie. osteoporosis) 

Gene-targeted electric stimulation for bone fractures and musculoskeletal injuries offer a non-invasive treatment delivery option for patients.